Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Briban Invest on the public offer for Sydsvenska Hem
Mandate

Vinge advises Briban Invest on the public offer for Sydsvenska Hem

February 28, 2025 Capital Markets and Public M&A Corporate Tax FDI

Briban Invest AB has made a public offer for all shares in Sydsvenska Hem AB (publ).

The offer values all shares in Sydsvenska Hem at approximately SEK 784 million, based on the cash alternative in the offer.

Vinge’s team consists of Erik Sjöman, Amanda Knutsson, Joel Magnusson, Anna Svensson and Vilma Henricsson (Capital Markets and Public M&A), Victor Ericsson, Erik Kochbati and Axel Åshuvud (Tax) and Sofie Nordgren and Jasmine Elgh (FDI).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025